サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1513979

消化性潰瘍検査の世界市場

Peptic Ulcer Testing

出版日
ページ情報
英文 193 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
消化性潰瘍検査の世界市場
出版日: 2024年07月17日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 193 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

消化性潰瘍検査の世界市場は2030年までに7億8,900万米ドルに達する見込み

2023年に5億4,280万米ドルと推定される消化性潰瘍検査の世界市場は、2023年から2030年にかけてCAGR 5.5%で成長し、2030年には7億8,900万米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるラボラトリーテストは、CAGR 6.0％を記録し、分析期間終了までに4億1,060万米ドルに達すると予測されます。上部内視鏡検査セグメントの成長率は、分析期間でCAGR 5.1％と推定されます。

米国市場は1億4,440万米ドルと推定、中国はCAGR5.1％で成長予測

米国の消化性潰瘍検査市場は、2023年に1億4,440万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに1億2,420万米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは5.1%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ5.0％と4.5％と予測されています。欧州では、ドイツがCAGR 4.1%で成長すると予測されています。

世界のグルコースモニタリングデバイス市場- 主要動向と促進要因のまとめ

グルコースモニタリングデバイスの市場は、技術の進歩、糖尿病有病率の増加、積極的な健康管理の重視の高まりに後押しされ、急速な成長を遂げています。世界の糖尿病罹患率は、肥満、高齢化、食生活の乱れや運動不足などの生活習慣などの要因により上昇しており、効果的なモニタリングソリューションの必要性が高まっています。持続血糖モニター（CGM）は大きく進化し、本来のインスリン療法をサポートする以上の高い精度と簡便性を提供しています。

市場の継続的拡大は、技術の進歩、ヘルスケアの統合、世界の糖尿病負担の増大にかかっています。非侵襲的技術、AI統合、ウェアラブルデバイスなどの革新が将来の展望を形成しており、糖尿病管理と患者ケアの強化が期待されています。これらのソリューションがより利用しやすくなるにつれて、世界の糖尿病管理が大幅に改善されることが期待され、特に新興国でヘルスケアインフラが強化されるにつれて、メーカーには十分な成長機会がもたらされます。

主な市場促進要因と動向には、グルコースレベルに関するリアルタイムの洞察を提供するCGMシステムなどの技術的飛躍や、グルコースモニタリングへのAIの統合が含まれます。これらのシステムは、経時的にデータを分析して将来のグルコース値の動向を予測し、潜在的な問題の先制管理を可能にします。人工知能（AI）は、糖尿病管理を含むヘルスケアの多くの側面を再構築しています。より良いスクリーニングとモニタリングを促進する政府の政策は、自己モニタリングを強調する患者教育とともに、採用をさらに促進しています。日常生活とシームレスに統合できるウェアラブル・グルコース・モニターが人気を集めています。これらのデバイスはグルコースレベルを継続的に追跡し、毎日何度も指を刺す検査を行う必要がないという利便性を提供します。

調査対象企業の例（注目の41社）

  • Beckman Coulter Inc.
  • Becton Dickinson and Company
  • Biohit Oyj
  • Biomerica Inc.
  • bioMerieux SA
  • Bio-Rad Laboratories Inc.
  • DiaSorin S.p.A.
  • EKF Diagnostics
  • Exalenz Bioscience Ltd.
  • Halyard Health Inc.
  • Kibion AB
  • Meridian Bioscience Inc.
  • Orion Diagnostica Oy
  • Otsuka America Pharmaceutical Inc.
  • Quidel Corporation
  • Sekisui Diagnostics LLC
  • Thermo Fischer Scientific Inc.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • 世界のその他の地域

第4章 競合

目次
Product Code: MCP-3417

Global Peptic Ulcer Testing Market to Reach US$789.0 Million by 2030

The global market for Peptic Ulcer Testing estimated at US$542.8 Million in the year 2023, is expected to reach US$789.0 Million by 2030, growing at a CAGR of 5.5% over the analysis period 2023-2030. Laboratory Tests, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$410.6 Million by the end of the analysis period. Growth in the Upper Endoscopy segment is estimated at 5.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$144.4 Million While China is Forecast to Grow at 5.1% CAGR

The Peptic Ulcer Testing market in the U.S. is estimated at US$144.4 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$124.2 Million by the year 2030 trailing a CAGR of 5.1% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.0% and 4.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.1% CAGR.

Global Glucose Monitoring Devices Market - Key Trends and Drivers Summarized

The market for glucose monitoring devices is experiencing rapid growth, fueled by technological advancements, increasing diabetes prevalence, and a rising emphasis on proactive health management. Global diabetes rates are climbing due to factors such as obesity, aging populations, and lifestyle habits such as poor diet and inactivity, amplifying the need for effective monitoring solutions. Continuous Glucose Monitors (CGMs) have evolved significantly, offering high accuracy and simplicity beyond their original insulin therapy support.

Continued market expansion hinges on technological progress, healthcare integration, and the escalating diabetes burden worldwide. Innovations like non-invasive technologies, AI integration, and wearable devices are shaping the future landscape, promising enhanced diabetes management and patient care. As these solutions become more accessible, they're expected to significantly improve global diabetes management, especially as healthcare infrastructure strengthens in emerging economies, presenting ample growth opportunities for manufacturers.

Key market drivers and trends include technological leaps such as CGM systems, which provide real-time insights into glucose levels, and the integration of AI into glucose monitoring, AI is increasingly being incorporated into glucose monitoring systems to enhance the predictive accuracy of devices. These systems can analyze data over time to predict future trends in glucose levels, enabling preemptive management of potential issues. Artificial Intelligence (AI) is reshaping many aspects of healthcare, including diabetes management Government policies promoting better screening and monitoring, alongside patient education emphasizing self-monitoring, further drive adoption. Wearable glucose monitors that seamlessly integrate with everyday life are gaining traction. These devices continuously track glucose levels and offer the convenience of not having to perform multiple daily finger-prick tests.

Select Competitors (Total 41 Featured) -

  • Beckman Coulter Inc.
  • Becton Dickinson and Company
  • Biohit Oyj
  • Biomerica Inc.
  • bioMerieux SA
  • Bio-Rad Laboratories Inc.
  • DiaSorin S.p.A.
  • EKF Diagnostics
  • Exalenz Bioscience Ltd.
  • Halyard Health Inc.
  • Kibion AB
  • Meridian Bioscience Inc.
  • Orion Diagnostica Oy
  • Otsuka America Pharmaceutical Inc.
  • Quidel Corporation
  • Sekisui Diagnostics LLC
  • Thermo Fischer Scientific Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Peptic Ulcer Testing - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Helicobacter pylori Infections Strengthens Business Case for Peptic Ulcer Testing
    • Growing Awareness of the Importance of Gut Health Drives Adoption of Regular Peptic Ulcer Testing
    • Increasing Adoption of Non-Invasive Testing Methods Expands Addressable Market Opportunity
    • Growth in Gastrointestinal Disorders Generates Demand for Comprehensive Peptic Ulcer Testing Solutions
    • Focus on Early Diagnosis and Prevention Throws the Spotlight on Rapid Peptic Ulcer Testing Solutions
    • Integration of AI and Machine Learning in Diagnostic Tools Enhances Test Accuracy and Speed
    • Rising Investment in Healthcare Infrastructure Generates Opportunities for Innovation in Peptic Ulcer Testing
    • Emphasis on Patient Comfort and Convenience Drives Adoption of Non-Invasive Testing Solutions
    • Adoption of Peptic Ulcer Testing in Routine Health Check-Ups Expands Addressable Market Opportunity
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Peptic Ulcer Testing Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Peptic Ulcer Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Peptic Ulcer Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Peptic Ulcer Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Laboratory Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Laboratory Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Laboratory Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Upper Endoscopy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Upper Endoscopy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Upper Endoscopy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Gastrointestinal Endoscopy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Gastrointestinal Endoscopy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Gastrointestinal Endoscopy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Peptic Ulcer Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Peptic Ulcer Testing by Diagnostic Test - Laboratory Tests, Upper Endoscopy and Gastrointestinal Endoscopy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Peptic Ulcer Testing by Diagnostic Test - Laboratory Tests, Upper Endoscopy and Gastrointestinal Endoscopy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Peptic Ulcer Testing by Diagnostic Test - Percentage Breakdown of Value Sales for Laboratory Tests, Upper Endoscopy and Gastrointestinal Endoscopy for the Years 2014, 2024 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Peptic Ulcer Testing by End-Use - Laboratories, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Peptic Ulcer Testing by End-Use - Laboratories, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Peptic Ulcer Testing by End-Use - Percentage Breakdown of Value Sales for Laboratories, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Peptic Ulcer Testing by Diagnostic Test - Laboratory Tests, Upper Endoscopy and Gastrointestinal Endoscopy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Peptic Ulcer Testing by Diagnostic Test - Laboratory Tests, Upper Endoscopy and Gastrointestinal Endoscopy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Peptic Ulcer Testing by Diagnostic Test - Percentage Breakdown of Value Sales for Laboratory Tests, Upper Endoscopy and Gastrointestinal Endoscopy for the Years 2014, 2024 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Peptic Ulcer Testing by End-Use - Laboratories, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Peptic Ulcer Testing by End-Use - Laboratories, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Peptic Ulcer Testing by End-Use - Percentage Breakdown of Value Sales for Laboratories, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
  • JAPAN
    • Peptic Ulcer Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Peptic Ulcer Testing by Diagnostic Test - Laboratory Tests, Upper Endoscopy and Gastrointestinal Endoscopy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Peptic Ulcer Testing by Diagnostic Test - Laboratory Tests, Upper Endoscopy and Gastrointestinal Endoscopy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Peptic Ulcer Testing by Diagnostic Test - Percentage Breakdown of Value Sales for Laboratory Tests, Upper Endoscopy and Gastrointestinal Endoscopy for the Years 2014, 2024 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Peptic Ulcer Testing by End-Use - Laboratories, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Peptic Ulcer Testing by End-Use - Laboratories, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Peptic Ulcer Testing by End-Use - Percentage Breakdown of Value Sales for Laboratories, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
  • CHINA
    • Peptic Ulcer Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Peptic Ulcer Testing by Diagnostic Test - Laboratory Tests, Upper Endoscopy and Gastrointestinal Endoscopy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Peptic Ulcer Testing by Diagnostic Test - Laboratory Tests, Upper Endoscopy and Gastrointestinal Endoscopy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Peptic Ulcer Testing by Diagnostic Test - Percentage Breakdown of Value Sales for Laboratory Tests, Upper Endoscopy and Gastrointestinal Endoscopy for the Years 2014, 2024 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Peptic Ulcer Testing by End-Use - Laboratories, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Peptic Ulcer Testing by End-Use - Laboratories, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Peptic Ulcer Testing by End-Use - Percentage Breakdown of Value Sales for Laboratories, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
  • EUROPE
    • Peptic Ulcer Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Peptic Ulcer Testing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Peptic Ulcer Testing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Peptic Ulcer Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Peptic Ulcer Testing by Diagnostic Test - Laboratory Tests, Upper Endoscopy and Gastrointestinal Endoscopy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Peptic Ulcer Testing by Diagnostic Test - Laboratory Tests, Upper Endoscopy and Gastrointestinal Endoscopy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Peptic Ulcer Testing by Diagnostic Test - Percentage Breakdown of Value Sales for Laboratory Tests, Upper Endoscopy and Gastrointestinal Endoscopy for the Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Peptic Ulcer Testing by End-Use - Laboratories, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Peptic Ulcer Testing by End-Use - Laboratories, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Peptic Ulcer Testing by End-Use - Percentage Breakdown of Value Sales for Laboratories, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
  • FRANCE
    • Peptic Ulcer Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Peptic Ulcer Testing by Diagnostic Test - Laboratory Tests, Upper Endoscopy and Gastrointestinal Endoscopy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Peptic Ulcer Testing by Diagnostic Test - Laboratory Tests, Upper Endoscopy and Gastrointestinal Endoscopy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Peptic Ulcer Testing by Diagnostic Test - Percentage Breakdown of Value Sales for Laboratory Tests, Upper Endoscopy and Gastrointestinal Endoscopy for the Years 2014, 2024 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Peptic Ulcer Testing by End-Use - Laboratories, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Peptic Ulcer Testing by End-Use - Laboratories, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Peptic Ulcer Testing by End-Use - Percentage Breakdown of Value Sales for Laboratories, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
  • GERMANY
    • Peptic Ulcer Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Peptic Ulcer Testing by Diagnostic Test - Laboratory Tests, Upper Endoscopy and Gastrointestinal Endoscopy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Peptic Ulcer Testing by Diagnostic Test - Laboratory Tests, Upper Endoscopy and Gastrointestinal Endoscopy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Peptic Ulcer Testing by Diagnostic Test - Percentage Breakdown of Value Sales for Laboratory Tests, Upper Endoscopy and Gastrointestinal Endoscopy for the Years 2014, 2024 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Peptic Ulcer Testing by End-Use - Laboratories, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Peptic Ulcer Testing by End-Use - Laboratories, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Peptic Ulcer Testing by End-Use - Percentage Breakdown of Value Sales for Laboratories, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Peptic Ulcer Testing by Diagnostic Test - Laboratory Tests, Upper Endoscopy and Gastrointestinal Endoscopy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Peptic Ulcer Testing by Diagnostic Test - Laboratory Tests, Upper Endoscopy and Gastrointestinal Endoscopy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Peptic Ulcer Testing by Diagnostic Test - Percentage Breakdown of Value Sales for Laboratory Tests, Upper Endoscopy and Gastrointestinal Endoscopy for the Years 2014, 2024 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Peptic Ulcer Testing by End-Use - Laboratories, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Peptic Ulcer Testing by End-Use - Laboratories, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Peptic Ulcer Testing by End-Use - Percentage Breakdown of Value Sales for Laboratories, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Peptic Ulcer Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Peptic Ulcer Testing by Diagnostic Test - Laboratory Tests, Upper Endoscopy and Gastrointestinal Endoscopy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Peptic Ulcer Testing by Diagnostic Test - Laboratory Tests, Upper Endoscopy and Gastrointestinal Endoscopy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Peptic Ulcer Testing by Diagnostic Test - Percentage Breakdown of Value Sales for Laboratory Tests, Upper Endoscopy and Gastrointestinal Endoscopy for the Years 2014, 2024 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Peptic Ulcer Testing by End-Use - Laboratories, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Peptic Ulcer Testing by End-Use - Laboratories, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Peptic Ulcer Testing by End-Use - Percentage Breakdown of Value Sales for Laboratories, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Peptic Ulcer Testing by Diagnostic Test - Laboratory Tests, Upper Endoscopy and Gastrointestinal Endoscopy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Rest of Europe Historic Review for Peptic Ulcer Testing by Diagnostic Test - Laboratory Tests, Upper Endoscopy and Gastrointestinal Endoscopy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Rest of Europe 16-Year Perspective for Peptic Ulcer Testing by Diagnostic Test - Percentage Breakdown of Value Sales for Laboratory Tests, Upper Endoscopy and Gastrointestinal Endoscopy for the Years 2014, 2024 & 2030
    • TABLE 83: Rest of Europe Recent Past, Current & Future Analysis for Peptic Ulcer Testing by End-Use - Laboratories, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Rest of Europe Historic Review for Peptic Ulcer Testing by End-Use - Laboratories, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Rest of Europe 16-Year Perspective for Peptic Ulcer Testing by End-Use - Percentage Breakdown of Value Sales for Laboratories, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Peptic Ulcer Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Peptic Ulcer Testing by Diagnostic Test - Laboratory Tests, Upper Endoscopy and Gastrointestinal Endoscopy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Asia-Pacific Historic Review for Peptic Ulcer Testing by Diagnostic Test - Laboratory Tests, Upper Endoscopy and Gastrointestinal Endoscopy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Asia-Pacific 16-Year Perspective for Peptic Ulcer Testing by Diagnostic Test - Percentage Breakdown of Value Sales for Laboratory Tests, Upper Endoscopy and Gastrointestinal Endoscopy for the Years 2014, 2024 & 2030
    • TABLE 89: Asia-Pacific Recent Past, Current & Future Analysis for Peptic Ulcer Testing by End-Use - Laboratories, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Asia-Pacific Historic Review for Peptic Ulcer Testing by End-Use - Laboratories, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Asia-Pacific 16-Year Perspective for Peptic Ulcer Testing by End-Use - Percentage Breakdown of Value Sales for Laboratories, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Peptic Ulcer Testing by Diagnostic Test - Laboratory Tests, Upper Endoscopy and Gastrointestinal Endoscopy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of World Historic Review for Peptic Ulcer Testing by Diagnostic Test - Laboratory Tests, Upper Endoscopy and Gastrointestinal Endoscopy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of World 16-Year Perspective for Peptic Ulcer Testing by Diagnostic Test - Percentage Breakdown of Value Sales for Laboratory Tests, Upper Endoscopy and Gastrointestinal Endoscopy for the Years 2014, 2024 & 2030
    • TABLE 95: Rest of World Recent Past, Current & Future Analysis for Peptic Ulcer Testing by End-Use - Laboratories, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of World Historic Review for Peptic Ulcer Testing by End-Use - Laboratories, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of World 16-Year Perspective for Peptic Ulcer Testing by End-Use - Percentage Breakdown of Value Sales for Laboratories, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION